13 research outputs found

    Lentivírus de pequenos ruminantes (CAEV e Maedi-Visna): revisão e perspectivas

    Full text link

    Pharmacological study of anti-allergic activity of Syzygium cumini (L.) Skeels

    No full text
    Myrtaceae is a plant family widely used in folk medicine and Syzygium and Eugenia are among the most important genera. We investigated the anti-allergic properties of an aqueous leaf extract of Syzygium cumini (L.) Skeels (SC). HPLC analysis revealed that hydrolyzable tannins and flavonoids are the major components of the extract. Oral administration of SC (25-100 mg/kg) in Swiss mice (20-25 g; N = 7/group) inhibited paw edema induced by compound 48/80 (50% inhibition, 100 mg/kg; P <= 0.05) and, to a lesser extent, the allergic paw edema (23% inhibition, 100 mg/kg; P <= 0.05). SC treatment also inhibited the edema induced by histamine (58% inhibition; P <= 0.05) and 5-HT (52% inhibition; P <= 0.05) but had no effect on platelet-aggregating factor-induced paw edema. SC prevented mast cell degranulation and the consequent histamine release in Wistar rat (180-200 g; N = 7/group) peritoneal mast cells (50% inhibition, 1 µg/mL; P <= 0.05) induced by compound 48/80. Pre-treatment of BALB/c mice (18-20 g; N = 7/group) with 100 mg/kg of the extract significantly inhibited eosinophil accumulation in allergic pleurisy (from 7.662 ± 1.524 to 1.89 ± 0.336 x 10(6)/cavity; P <= 0.001). This effect was related to the inhibition of IL-5 (from 70.9 ± 25.2 to 12.05 ± 7.165 pg/mL) and CCL11/eotaxin levels (from 60.4 ± 8.54 to 32.8 ± 8.4 ng/mL) in pleural lavage fluid, using ELISA. These findings demonstrate an anti-allergic effect of SC, and indicate that its anti-edematogenic effect is due to the inhibition of mast cell degranulation and of histamine and serotonin effects, whereas the inhibition of eosinophil accumulation in the allergic pleurisy model is probably due to an impairment of CCL11/eotaxin and IL-5 production

    Custo e resultados do tratamento de seqüelas de laminite bovina: relato de 112 casos em vacas em lactação no sistema free-stall Results and costs of treatment for bovine laminitis sequelae: study of 112 lameness cases in lactating cows in free-stall system

    No full text
    Os resultados e o custo do tratamento de seqüelas podais da laminite subclínica são descritos em 112 casos de manqueira em vacas em lactação mantidas no sistema free-stall. As observações feitas durante um ano abrangeram animais de 2,5 a 10 anos de idade, da primeira à sexta lactação e com média de produção de 8.000±2.000kg de leite. O protocolo de tratamento, descrito detalhadamente para cada uma das afecções podais, foi eficiente na reversão de todas elas. O custo total do tratamento para o rebanho foi de US5,005.23,equivalenteaocustomeˊdiodeUS5,005.23, equivalente ao custo médio de US44.68 por animal. O tratamento das úlceras de sola foi o mais dispendioso (US72.58)eomaisdemorado(26,8dias).Asafecc\co~esmaiscomunsforamosabscessosdesolaedotala~oeasleso~esdalinhabranca(64/112ou57,272.58) e o mais demorado (26,8 dias). As afecções mais comuns foram os abscessos de sola e do talão e as lesões da linha branca (64/112 ou 57,2%).<br>The results and costs of treatments of feet sequelae of subclinic dairy cattle laminitis were described in 112 cases of lameness in lactating cows maintained in free stall system. The analyses were performed in an one-year-period using 2.5 to 10 year-old, first to sixth parity cows. Average milk yield was 8,000±2,000kg. The treatment protocol was described in details for each digit lesion and it was very successful to reverse all kinds of lesions. The total treatment cost for the herd was US5,005.23 and the mean cost/animal was US44.68.Theulcertreatmentswerecostly(US44.68. The ulcer treatments were costly (US72.58) and longer (26.8 days). Sole and heel abscesses and white line disease at the foe (64/112 or 57.2%) were most commonly observed
    corecore